EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of E2F transcription factor in oral cancer: Recent insight and advancements

Amal Kassab, Ishita Gupta, Ala-Eddin Al Moustafa

Seminars in Cancer Biology · 2023-07 · 92 · 28-41

DOI: 10.1016/j.semcancer.2023.03.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-07. Verfasst von Amal Kassab und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Faculty of Medicine, McGill University, 3775 University Street, Montreal, QC H3A 2BA, Canada. Hauptthemen laut MEDLINE: Transcription Factors, Mouth Neoplasms. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University, Qatar National Research Fund, Qatar National Library.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The family of mammalian E2F transcription factors (E2Fs) comprise of 8 members (E2F1-E2F8) classified as activators (E2F1-E2F3) and repressors (E2F4-E2F8) primarily regulating the expression of several genes related to cell proliferation, apoptosis and differentiation, mainly in a cell cycle-dependent manner. E2F activity is frequently controlled via the retinoblastoma protein (pRb), cyclins, p53 and the ubiquitin-proteasome pathway. Additionally, genetic or epigenetic changes result in the deregulation of E2F family genes expression altering S phase entry and apoptosis, an important hallmark for the onset and development of cancer. Although studies reveal E2Fs to be involved in several human malignancies, the mechanisms underlying the role of E2Fs in oral cancer lies nascent and needs further investigations. This review focuses on the role of E2Fs in oral cancer and the etiological factors regulating E2Fs activity, which in turn transcriptionally control the expression of their target genes, thus contributing to cell proliferation, metastasis, and drug/therapy resistance. Further, we will discuss therapeutic strategies for E2Fs, which may prevent oral tumor growth, metastasis, and drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsMouth NeoplasmsAnimalsHumansE2F Transcription FactorsCell CycleCell Cycle ProteinsMammals

Stichwörter der Autor:innen

AgeingE2FHPVOral cancerTherapeutic targetsTranscription factors

Substanzen

E2F Transcription FactorsTranscription FactorsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Faculty of Medicine, McGill University, 3775 University Street, Montreal, QC H3A 2BA, Canada.
  • Research Department, Sidra Medicine, Member of Qatar Foundation, P.O. Box 26999, Doha, Qatar.
  • College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar; Oncology Department, Faculty of Medicine, McGill University, Montre…

Förderung

  • Qatar University
  • Qatar National Research Fund
  • Qatar National Library

Zitieren

APA

Kassab, A., Gupta, I., & Moustafa, A. A. (2023). Role of E2F transcription factor in oral cancer: Recent insight and advancements. Seminars in Cancer Biology, 92, 28-41. https://doi.org/10.1016/j.semcancer.2023.03.004

Vancouver

Kassab A, Gupta I, Moustafa AA. Role of E2F transcription factor in oral cancer: Recent insight and advancements. Seminars in Cancer Biology. 2023;92:28-41. doi:10.1016/j.semcancer.2023.03.004

BibTeX
@article{Kassab2023,
  author = {Kassab, Amal and Gupta, Ishita and Moustafa, Ala-Eddin Al},
  title = {Role of E2F transcription factor in oral cancer: Recent insight and advancements},
  journal = {Seminars in Cancer Biology},
  year = {2023},
  volume = {92},
  pages = {28--41},
  doi = {10.1016/j.semcancer.2023.03.004}
}
Kostenlos starten →